Event Panel Schedule

Zoom #47 [Zoom]
Keynote: Cur­rent Cap­i­tals Mar­kets Overview
Goldman Sachs & Co.
Ben Thorpe , Head of European Healthcare Investment Banking / Goldman Sachs & Co.
Ben is a Partner managing director in the Healthcare Investment Banking Team, which he joined in 1999. He has a degree form University of Durham.

Zoom #46 [Zoom]
What It Takes: A Suc­cess­ful U.S. IPO in A New Vir­tu­al World
CureVac AG
Franz-Werner Haas , Acting Chief Executive Officer, Chief Operating Officer / CureVac AG
Franz-Werner Haas joined CureVac in June 2012. Before joining CureVac, he was Vice President Operations and Chief Compliance Officer of SYGNIS Pharma AG, where he was responsible for the execution of M&A and capital market transactions…

Goodwin Procter LLP
Robert Puopolo , Partner / Goodwin Procter LLP
Rob Puopolo, a partner in Goodwin’s Life Sciences practice, focuses his practice on representing public and privately held life sciences companies, as well as the venture capital firms, hedge funds and investment banks that focus on these companies.

SVB Leerink
Gabriel P. Cavazos , Managing Director / SVB Leerink
Gabriel Cavazos has been with Leerink Swann in the Healthcare Banking Division since 2008. Prior to that he worked in M&A at JP Morgan and previously at Merck and Pfizer. He has a BSc in Cellular & Molecular Biology from the University of…

Zoom #39
Al­ter­na­tives to IPOs: Re­v­erse Merg­ers, Di­rect List­ings, SPACs, Cross-Over Fi­nanc­ings, and De-Risk­ing Strate­gies
Immatics NV
Harpreet Singh, PhD , CEO / Immatics Biotechnologies GmbH

Goodwin Procter LLP
Jocelyn Arel / Goodwin Procter LLP
Jocelyn Arel is a pioneer in the U.S. for her innovative work for clients on SPACs, with nearly two decades of successful SPACs transactions under her belt. Ms. Arel advises clients in all aspects of the SPAC lifecycle, including the formation and…

Jefferies LLC
Gil Bar-Nahum , Managing Director / Jefferies LLC
Dr. Gil Bar-Nahum is a Managing Director in the Global Healthcare Investment Banking Group and leads the International Biotechnology effort at Jefferies. Dr. Bar-Nahum has over 17 years of experience and was an Executive Director in UBS Investment…

Solebury Trout
Chad Rubin , Managing Director / Solebury Trout
Chad has more than 18 years of experience in advising life science companies on topics including shareholder targeting, investor roadshows, capital markets transactions, messaging, and scenario analysis. His experience includes work in finance…

Zoom #46 [Zoom]
IPO Readi­ness: Suc­cess Fac­tors and Se­crets and Best Prac­tices for Eu­ro­pean For­eign Pri­vate Is­suers
Ernst & Young
Dr. Martin Steinbach , Partner, Head of IPO and Listing Services / Ernst & Young
A partner at one of the EY member firms in Germany, Martin is the EY EMEIA IPO Leader as well as the Head of IPO and Listing Services for EY GSA (Germany, Switzerland and Austria). He focuses on IPOs, investor relations, mergers and acquisitions, and…

Deutsche Bank AG
Joseph Oakenfold , Vice President / Deutsche Bank AG
Joe Oakenfold is the lead salesperson for Deutsche Banks‘ Depositary Receipts business in Europe bringing corporate issuers to the US capital markets and enabling access to the worlds’ largest pool of investment. With over 20 years’ experience, Joe…

Ernst & Young
Dirk Gallowsky , Partner / Ernst & Young

Paul van der Bijl / NautaDutilh
Paul van der Bijl focuses on IPOs, follow-on offerings, public M&A, anti-takeover defenses, corporate governance and complex cross-border transactions. Notable transactions that Paul has been involved in include: the NASDAQ IPOs of InflaRx…

Solebury Trout
Brian Korb , Managing Director / Solebury Trout
Brian Korb is a Managing Director based in New York. Since joining the firm in 2000, Brian has worked with hundreds of companies in the life sciences space, crafting and executing investor relations and communication plans. He is a trusted advisor…
Export to Excel